Two new Covid drugs, Baricitinib and Sotrovimab approved by WHO

Baricitinib

The World Health Organisation Guideline Development Group of international experts has recommended approving two new covid drugs in the BMJ. This is after a trial that involved over 4000 patients with a different level of severity of Covid-19 infections. The drug, Baricitinib, a Janus kinase (JAK) inhibitor, is used to treat rheumatoid arthritis. WHO recommends … Read more